Cleared Traditional

K844373 - O.M.S. ULTRA-PHACO

K844373 is an FDA 510(k) clearance for O.M.S. ULTRA-PHACO, manufactured by Optical Micro Systems, Inc.. The device is a Class 2 Ophthalmic device with product code HQC cleared through the Traditional 510(k) pathway after a 401-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1985
Decision
401d
Days
Class 2
Risk

K844373 is an FDA 510(k) clearance for the O.M.S. ULTRA-PHACO. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Optical Micro Systems, Inc. (Danvers, US). The FDA issued a Cleared decision on December 19, 1985 after a review of 401 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Ophthalmic submissions.

FDA 510(k) Submission Details - K844373

510(k) Number K844373 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 13, 1984
Decision Date December 19, 1985
Days to Decision 401 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
291d slower than avg
Panel avg: 110d · This submission: 401d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 316
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K844373.
PHACO PACKS, 1A PACKS & PACK COMPONENTS
K854116 · Medical Corp. of America · Dec 1985
ALLERGAN I.S.P. MODEL 3000 OPHTHALMIC SURGICAL-SYS
K854225 · Advanced Medical Technology, Inc. · Dec 1985
COOPERVISION ACAP POWER DRIVE ULTRASONIC ANTERIOR
K854375 · CooperVision, Inc. · Dec 1985
TUBING A VIT, VIT, FRAG PACKS & NEEDLE & CLEAN WIR
K853883 · Medical Corp. of America · Oct 1985
CREAT BRAND I/A PACK CREAT BRAND PHACO PACK
K853189 · Aesthetech Corp. · Sep 1985
PHACO-BAC STOP FILTER KIT
K852208 · Staar Surgical Co. · Aug 1985